Correlation Between Clal Biotechnology and Evogene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Evogene, you can compare the effects of market volatilities on Clal Biotechnology and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Evogene.

Diversification Opportunities for Clal Biotechnology and Evogene

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Clal and Evogene is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Evogene go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Evogene

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to generate 1.02 times more return on investment than Evogene. However, Clal Biotechnology is 1.02 times more volatile than Evogene. It trades about -0.01 of its potential returns per unit of risk. Evogene is currently generating about -0.12 per unit of risk. If you would invest  4,740  in Clal Biotechnology Industries on September 1, 2024 and sell it today you would lose (1,060) from holding Clal Biotechnology Industries or give up 22.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Evogene

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Evogene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Clal Biotechnology and Evogene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Evogene

The main advantage of trading using opposite Clal Biotechnology and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.
The idea behind Clal Biotechnology Industries and Evogene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals